Abiraterone in patients with recurrent epithelial ovarian cancer: principal results of the phase II Cancer of the Ovary Abiraterone (CORAL) trial (CRUK - A16037).
Banerjee S, Tovey H, Bowen R, Folkerd E, Kilburn L, McLachlan J, Hall M, Tunariu N, Attygalle A, Lima JPDSN, Perry S, Chatfield P, Hills M, Kaye S, Attard G, Dowsett M, Bliss JM.
Banerjee S, et al. Among authors: mclachlan j.
Ther Adv Med Oncol. 2020 Dec 29;12:1758835920975352. doi: 10.1177/1758835920975352. eCollection 2020.
Ther Adv Med Oncol. 2020.
PMID: 33854564
Free PMC article.